Ash Cooper
Cancer Immunotherapy Effective Across All Ages Despite Age-Related Immune Differences
A groundbreaking study from Johns Hopkins Medicine reveals that older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors (ICIs)—a class of life-saving cancer immunotherapy drugs. This promising discovery counters longstanding concerns that age-related immune system changes might reduce treatment effectiveness in elderly patients.
· 3 min read











